Amgen Inc. (ETR:AMG)
Germany
· Delayed Price · Currency is EUR 240.85
-4.75 (-1.93%)
May 21, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Prolia | 4.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prolia Growth | 8.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ENBREL | 3.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ENBREL Growth | -11.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| XGEVA | 2.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| XGEVA Growth | 4.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nplate | 1.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nplate Growth | 1.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Aranesp | 1.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Aranesp Growth | -1.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Products | 5.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Products Growth | 20.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | 32.78B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | 16.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -0.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| KYPROLIS | 1.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| KYPROLIS Growth | 2.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Repatha | 2.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Repatha Growth | 33.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Otezla | 2.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Otezla Growth | -0.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EVENITY | 1.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EVENITY Growth | 33.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BLINCYTO | 1.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BLINCYTO Growth | 47.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vectibix | 1.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vectibix Growth | 6.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| TEZSPIRE | 1.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| TEZSPIRE Growth | 68.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| TEPEZZA | 1.81B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| TEPEZZA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| KRYSTEXXA | 1.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| KRYSTEXXA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| U.S. |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| U.S. Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World (ROW) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World (ROW) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| McKesson Corporation Revenue |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| McKesson Corporation Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cencora, Inc. (formerly Amerisource Bergen Corporation) Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardinal Health, Inc. Revenue |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardinal Health, Inc. Revenue Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|